Solasto Corporation

6197.T
Medical Care Facilities
2026/07/15 Updated
Market Cap: $620.7M (¥100.6B)
Stock Price: $6.85 (¥1,111)
Exchange Rate: 1 USD = ¥162.07

Notice Regarding Resolution for Approval of Share Consolidation, Abolition of the Unit Share, and Partial Amendment of Articles of Incorporation

Approval of share consolidation and partial amendment to the Articles of Incorporation decided at an extraordinary general meeting. Consolidation ratio set at 1 share per 2,120,340 shares; delisting date planned for August 6, 2026. Details on fractional share handling, sale method, and funds for the offeror.

Importance:
Page Updated: July 6, 2026
IR Disclosure Date: July 6, 2026

Key Figures

  • Share Consolidation Ratio: 1 share per 2,120,340 shares
  • Delisting Date (planned): 2026年8月6日
  • Effective Date (planned): 2026年8月10日

AI要約

Approval of Share Consolidation and Amendment to Articles of Incorporation

At the extraordinary general meeting, Proposal 1 for share consolidation and Proposal 2 for partial amendment to the Articles of Incorporation were approved as originally proposed. Fractional shares below 1 share after consolidation will be settled by cash payment in accordance with the Companies Act. As a result of the consolidation, the shares will be delisted, and after the record date of August 6, 2026, a residual stock designation will be established; from August 9 to 11, 2026, proceeds from the sale of fractional shares are expected to be distributed to shareholders.

Fractional Share Handling and Funding

Fractions will be settled through the sale of fractional shares. The offeror will secure funds via funds such as MBK Partners, and approximately 49,999 shares worth of funds will be secured through a related company led by Toru Noda. Subject to court approval, fractional shares will be sold and proceeds distributed to shareholders.

Soralyst Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →